Clinical Trial Update: Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of Xyrem (sodium oxybate) in combination with Zolpidem on sleep-disordered breathing in obstructive sleep apnea patients; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Ambien (zolpidem)
• Xyrem (Sodium Oxybate)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Obstructive Sleep Apnea Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2012-02-24